Answers are grounded in this paper and cite their sources.
Hybrid modeling approaches enhance molecular dynamics simulations, indicating improved protein-ligand interaction accuracy.
Recent advances in machine learning (ML) have enabled new developments in molecular dynamics simulation. Neural network potentials (NNPs) trained on quantum mechanical (QM) data provide highly accurate descriptions of drug-like molecules. Analogous to a QM and molecular mechanical (QM/MM) approach, hybrid ML/MM simulations employ NNPs to describe a localized region of the system, such as a ligand, while the rest of the system is treated using classical MM force fields. This hybrid framework enables simulations of protein-ligand complexes with near-QM accuracy for the ligand at a substantially reduced computational cost. CHARMM-GUI Hybrid ML/MM Builder automates the preparation of system and input files required for hybrid ML/MM modeling and simulation. This new module generates all necessary files to simulate protein-ligand complexes in solution or membrane using TorchANI-AMBER and OpenMM-ML. Currently supported NNPs include MACE and ANI. In this paper, we present Hybrid ML/MM Builder and representative application systems that demonstrate its usage and capabilities.
No takes yet. Share an insight, caveat, or question.
Szczepaniak et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: